Carl Zeiss Meditec AG (AFX) — Capital Reinvestment Ratio
Latest as of September 2025:
0.36x
Carl Zeiss Meditec AG (AFX) has a Capital Reinvestment Ratio of 0.36x as of September 2025, meaning it reinvests 0% of its operating cash flow (€209.86 Million) in capital expenditures (€76.59 Million). See AFX cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.36x
Capex / Operating Cash Flow
Operating Cash Flow
€209.86 Million
EUR
Capital Expenditures
€76.59 Million
EUR
Data as of
Sep 2025
Most recent filing
Carl Zeiss Meditec AG Capital Reinvestment Ratio (2014–2025)
This chart tracks Carl Zeiss Meditec AG's Capital Reinvestment Ratio across 12 annual periods.
Annual Capital Reinvestment Ratio for Carl Zeiss Meditec AG (2014–2025)
Year-by-year Capital Reinvestment Ratio for Carl Zeiss Meditec AG from 2014 to 2025. For live market cap and broader valuation context, see market cap of Carl Zeiss Meditec AG.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.36x | €209.86 Million | €76.59 Million | ▼ -40.7% |
| 2024 | 0.62x | €247.32 Million | €152.20 Million | ▲ +135.2% |
| 2023 | 0.26x | €250.86 Million | €65.65 Million | ▲ +15.1% |
| 2022 | 0.23x | €188.20 Million | €42.80 Million | ▲ +173.8% |
| 2021 | 0.08x | €362.66 Million | €30.12 Million | ▼ -49.4% |
| 2020 | 0.16x | €178.53 Million | €29.32 Million | ▲ +77.3% |
| 2019 | 0.09x | €219.63 Million | €20.35 Million | ▲ +4.9% |
| 2018 | 0.09x | €187.21 Million | €16.54 Million | ▼ -75.6% |
| 2017 | 0.36x | €37.73 Million | €13.66 Million | ▲ +44.9% |
| 2016 | 0.25x | €111.77 Million | €27.92 Million | ▲ +45.0% |
| 2015 | 0.17x | €56.74 Million | €9.77 Million | ▼ -2.5% |
| 2014 | 0.18x | €63.10 Million | €11.14 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow